| # | Drug | Count |
|---|---|---|
| 0 | ROSUVASTATIN | 26 |
| 1 | EVOLOCUMAB | 20 |
| 2 | ASPIRIN | 15 |
| 3 | ASPIRIN 325 MG | 14 |
| 4 | ASPIRIN 81 MG | 14 |
| 5 | EZETIMIBE | 13 |
| 6 | CARVEDILOL | 9 |
| 7 | EPLERENONE | 8 |
| 8 | RAMIPRIL | 8 |
| 9 | SACUBITRIL AND VALSARTAN | 8 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BEMPEDOIC ACID AND EZETIMIBE | 1 | 0.0014 |
| 1 | IVABRADINE | 6 | 0.0009 |
| 2 | BEMPEDOIC ACID | 2 | 0.0007 |
| 3 | EPLERENONE | 8 | 0.0006 |
| 4 | ALPROSTADIL | 2 | 0.0006 |
| 5 | ROMOSOZUMAB-AQQG | 6 | 0.0004 |
| 6 | ROSUVASTATIN | 26 | 0.0003 |
| 7 | TORSEMIDE | 8 | 0.0002 |
| 8 | ASFOTASE ALFA | 2 | 0.0002 |
| 9 | EZETIMIBE | 13 | 0.0002 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | PCSK9 Inhibitor [EPC] | 23 | 0.0009 |
| 1 | Adenosine Triphosphate-Citrate Lyase Inhibitor [EPC] | 2 | 0.0006 |
| 2 | Sulfonamide Antibacterial [EPC] | 1 | 0.0003 |
| 3 | Tissue-nonspecific Alkaline Phosphatase [EPC] | 2 | 0.0002 |
| 4 | Dietary Cholesterol Absorption Inhibitor [EPC] | 13 | 0.0001 |
| 5 | Gonadotropin Releasing Hormone Receptor Antagonist [EPC] | 2 | 0.0001 |
| 6 | Angiotensin Converting Enzyme Inhibitor [EPC] | 9 | 0.0001 |
| 7 | Parathyroid Hormone-Related Peptide Analog [EPC] | 2 | 0.0001 |
| 8 | alpha-Adrenergic Blocker [EPC] | 9 | 0.0001 |
| 9 | HMG-CoA Reductase Inhibitor [EPC] | 22 | 0.0001 |